Flunarizine vs. propranolol for migraine in children
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests two medicines—flunarizine and propranolol—to see which one works better for preventing migraines in children ages 8 to 15. If your child has frequent migraines that affect their daily life, this study may help find a treatment that works for them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 8 and 15 years old
- Your child has been diagnosed with migraine (with or without aura) by a doctor
- Your child has had at least 4 migraine attacks per month for the past 3 months
- Your child's migraines cause moderate to severe problems at school, home, or play (measured by a special score called PedMIDAS)
- Your child does not have heart problems, asthma, or allergies to flunarizine or propranolol
- Your child is able to attend regular check-ups and has not been in another drug study in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different first-time preventive treatments for migraine in a primary care setting. If you qualify, you'll receive one of the study medications, and the research team will track how well it reduces your migraine days.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This trial compares two medicines taken daily to prevent migraine headaches, with the goal of reducing how often they happen.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This study looks at how migraine may start or affect children by comparing young people who either have migraine symptoms or are at higher risk. It may help researchers understand migraine patterns and who could benefit from early prevention.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.